Literature DB >> 16418854

Tiagabine and vigabatrin reduce the severity of NMDA-induced excitotoxicity in chick retina.

Francesco Pisani1, Cinzia Costa, Daniela Caccamo, Emanuela Mazzon, Gaetano Gorgone, Giancarla Oteri, Paolo Calabresi, Riccardo Ientile.   

Abstract

The possible neuroprotective effects of two GABAergic drugs, tiagabine (TGB) and vigabatrin (VGB), against N-methyl-D-aspartate (NMDA)-induced excitotoxicity have been investigated in the isolated chick embryo retina model. Retina segments were incubated either with NMDA alone (100 microM) or with NMDA and TGB or VGB (10-1,000 microM, added 5 min before NMDA). Retina damage was assessed after 24 h by measuring lactate dehydrogenase (LDH) activity present in the medium and by histological analysis. Both drugs reduced LDH release in a dose-dependent manner with comparable mean maximal values of 56.6-63.7% achieved at concentration of 1 mM. Histological analysis of retina slices was in line with the biochemical assays and showed partial preservation of drug exposed retina structure with reduced edema especially in the inner plexiform layer. The present data provide pharmacological evidence that both TGB and VGB reduce the severity of NMDA-induced excitotoxic damage. Although an increase in GABAergic transmission might play a role, this in itself is insufficient to explain the neuroprotective effect of the two drugs and the exact mechanism remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16418854     DOI: 10.1007/s00221-005-0298-1

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  28 in total

1.  Elevated gamma-aminobutyric acid levels attenuate the metabolic response to bilateral ischemia.

Authors:  M S Abel; D W McCandless
Journal:  J Neurochem       Date:  1992-02       Impact factor: 5.372

Review 2.  Apoptosis in the retina.

Authors:  P S Rosenbaum; H Gupta; S I Savitz; D M Rosenbaum
Journal:  Clin Neurosci       Date:  1997

3.  Postischemic inhibition of GABA reuptake by tiagabine slows neuronal death in the gerbil hippocampus.

Authors:  J R Inglefield; J M Perry; R D Schwartz
Journal:  Hippocampus       Date:  1995       Impact factor: 3.899

4.  Morphological and electrophysiological evidence for an ionotropic GABA receptor of novel pharmacology.

Authors:  D-W Shen; M H Higgs; D Salvay; J W Olney; P D Lukasiewicz; C Romano
Journal:  J Neurophysiol       Date:  2002-01       Impact factor: 2.714

5.  A controlled study comparing visual function in patients treated with vigabatrin and tiagabine.

Authors:  G L Krauss; M A Johnson; S Sheth; N R Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-03       Impact factor: 10.154

6.  Effects of vigabatrin (gamma-vinyl GABA) on neurotransmission-related amino acids and on GABA and benzodiazepine receptor binding in rats.

Authors:  T Halonen; A Pitkänen; V Saano; P J Riekkinen
Journal:  Epilepsia       Date:  1991 Mar-Apr       Impact factor: 5.864

7.  Excitotoxic index--a biochemical marker of selective vulnerability.

Authors:  M Y Globus; M D Ginsberg; R Busto
Journal:  Neurosci Lett       Date:  1991-06-10       Impact factor: 3.046

8.  Coactivation of GABA(A) and GABA(B) receptor results in neuroprotection during in vitro ischemia.

Authors:  Cinzia Costa; Giorgia Leone; Emilia Saulle; Francesco Pisani; Giorgio Bernardi; Paolo Calabresi
Journal:  Stroke       Date:  2004-01-15       Impact factor: 7.914

9.  Gamma-vinyl GABA prevents hippocampal and substantia nigra reticulata damage in repetitive transient forebrain ischemia.

Authors:  A Shuaib; S Ijaz; S Hasan; J Kalra
Journal:  Brain Res       Date:  1992-09-11       Impact factor: 3.252

10.  Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retina.

Authors:  Graeme J Sills; Elaine Butler; Gerard Forrest; Neville Ratnaraj; Philip N Patsalos; Martin J Brodie
Journal:  Epilepsia       Date:  2003-07       Impact factor: 5.864

View more
  3 in total

Review 1.  Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs.

Authors:  D Caccamo; L R Pisani; P Mazzocchetti; R Ientile; P Calabresi; F Pisani; C Costa
Journal:  Neurochem Res       Date:  2015-12-31       Impact factor: 3.996

2.  New GABA modulators protect photoreceptor cells from light-induced degeneration in mouse models.

Authors:  Rebecca M Schur; Songqi Gao; Guanping Yu; Yu Chen; Akiko Maeda; Krzysztof Palczewski; Zheng-Rong Lu
Journal:  FASEB J       Date:  2018-01-24       Impact factor: 5.191

3.  Activation of 5-HT1A Receptors Promotes Retinal Ganglion Cell Function by Inhibiting the cAMP-PKA Pathway to Modulate Presynaptic GABA Release in Chronic Glaucoma.

Authors:  Xujiao Zhou; Rong Zhang; Shenghai Zhang; Jihong Wu; Xinghuai Sun
Journal:  J Neurosci       Date:  2018-12-12       Impact factor: 6.167

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.